BrightSpring Historical Financial Ratios
BTSG Stock | 21.19 0.30 1.44% |
BrightSpring Health is presently reporting on over 80 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.04 or Days Sales Outstanding of 49.01 will help investors to properly organize and evaluate BrightSpring Health financial condition quickly.
BrightSpring |
About BrightSpring Financial Ratios Analysis
BrightSpring HealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BrightSpring Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BrightSpring financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BrightSpring Health history.
BrightSpring Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing BrightSpring Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BrightSpring Health sales, a figure that is much harder to manipulate than other BrightSpring Health Services, multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from BrightSpring Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BrightSpring Health current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightSpring Health Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At this time, BrightSpring Health's Stock Based Compensation To Revenue is most likely to slightly decrease in the upcoming years. The BrightSpring Health's current PB Ratio is estimated to increase to 3.04, while Book Value Per Share is projected to decrease to 3.91.
2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 41.05 | 41.8 | 48.07 | 49.01 | PTB Ratio | 2.49 | 3.22 | 2.9 | 3.04 |
BrightSpring Health fundamentals Correlations
Click cells to compare fundamentals
BrightSpring Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BrightSpring Health fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 0.0147 | 0.28 | 0.24 | 0.21 | 0.19 | 0.1 | |
Days Sales Outstanding | 45.84 | 43.87 | 41.05 | 41.8 | 48.07 | 49.01 | |
Book Value Per Share | 98.68 | 4.68 | 4.58 | 3.58 | 4.11 | 3.91 | |
Free Cash Flow Yield | 2.08 | 0.11 | (0.0397) | 0.0729 | 0.0838 | 0.0796 | |
Operating Cash Flow Per Share | 29.88 | 1.58 | (0.0272) | 1.23 | 1.42 | 1.35 | |
Stock Based Compensation To Revenue | 0.001123 | 6.74E-4 | 4.59E-4 | 4.44E-4 | 5.1E-4 | 7.74E-4 | |
Capex To Depreciation | 0.29 | 0.3 | 0.34 | 0.36 | 0.42 | 0.37 | |
Ev To Sales | 0.5 | 0.84 | 0.72 | 0.63 | 0.56 | 0.52 | |
Free Cash Flow Per Share | 22.91 | 1.23 | (0.44) | 0.8 | 0.92 | 0.88 | |
Roic | 0.0541 | 0.0367 | 0.0729 | 0.0296 | 0.0266 | 0.0353 | |
Inventory Turnover | 15.1 | 18.21 | 14.79 | 18.35 | 21.11 | 18.71 | |
Net Income Per Share | 2.79 | 0.29 | (0.31) | (0.9) | (0.81) | (0.85) | |
Days Of Inventory On Hand | 24.17 | 20.04 | 24.68 | 19.89 | 17.9 | 17.34 | |
Payables Turnover | 12.74 | 13.35 | 12.08 | 11.52 | 13.25 | 14.15 | |
Capex To Revenue | 0.009302 | 0.008849 | 0.009081 | 0.008331 | 0.00958 | 0.011 | |
Cash Per Share | 35.16 | 0.27 | 0.0796 | 0.0764 | 0.0878 | 0.0834 | |
Pocfratio | 0.37 | 6.97 | (404.71) | 8.93 | 10.27 | 10.79 | |
Interest Coverage | 1.97 | 1.42 | 1.27 | 0.45 | 0.52 | 0.5 | |
Capex To Operating Cash Flow | 0.23 | 0.22 | (15.07) | 0.35 | 0.4 | 0.42 | |
Pfcf Ratio | 0.48 | 8.93 | (25.19) | 13.72 | 15.78 | 16.57 | |
Days Payables Outstanding | 28.65 | 27.33 | 30.21 | 31.68 | 28.51 | 22.86 | |
Income Quality | 10.7 | 5.27 | 0.0863 | (1.36) | (1.23) | (1.17) | |
Roe | 0.0295 | 0.0643 | (0.0714) | (0.26) | (0.3) | (0.29) | |
Ev To Operating Cash Flow | 12.55 | 20.75 | (1.2K) | 26.29 | 30.23 | 31.74 | |
Pe Ratio | 3.94 | 37.81 | (34.93) | (12.18) | (14.01) | (13.31) | |
Return On Tangible Assets | 0.0106 | 0.0286 | (0.0258) | (0.0757) | (0.087) | (0.0827) | |
Ev To Free Cash Flow | 16.37 | 26.59 | (74.24) | 40.37 | 46.42 | 48.74 | |
Earnings Yield | 0.25 | 0.0264 | (0.0286) | (0.0821) | (0.0739) | (0.0776) | |
Net Debt To E B I T D A | 7.82 | 8.59 | 7.33 | 10.46 | 9.42 | 6.8 | |
Current Ratio | 1.74 | 1.32 | 1.44 | 1.17 | 1.34 | 1.55 | |
Tangible Book Value Per Share | (272.4) | (17.34) | (16.17) | (16.81) | (15.13) | (15.88) | |
Receivables Turnover | 7.96 | 8.32 | 8.89 | 8.73 | 7.86 | 6.59 | |
Graham Number | 77.1 | 5.44 | 5.59 | 8.33 | 9.58 | 9.1 | |
Shareholders Equity Per Share | 94.6 | 4.53 | 4.41 | 3.42 | 3.93 | 3.73 | |
Debt To Equity | 4.22 | 4.87 | 4.88 | 6.28 | 5.65 | 3.83 | |
Capex Per Share | 6.97 | 0.35 | 0.41 | 0.43 | 0.49 | 0.47 | |
Graham Net Net | (410.28) | (22.86) | (23.21) | (23.06) | (20.75) | (21.79) |
Currently Active Assets on Macroaxis
When determining whether BrightSpring Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if BrightSpring Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Brightspring Health Services, Stock. Highlighted below are key reports to facilitate an investment decision about Brightspring Health Services, Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightSpring Health Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BrightSpring Health. If investors know BrightSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BrightSpring Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.333 | Earnings Share (0.22) | Revenue Per Share | Quarterly Revenue Growth 0.288 | Return On Assets |
The market value of BrightSpring Health is measured differently than its book value, which is the value of BrightSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BrightSpring Health's value that differs from its market value or its book value, called intrinsic value, which is BrightSpring Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BrightSpring Health's market value can be influenced by many factors that don't directly affect BrightSpring Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BrightSpring Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrightSpring Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrightSpring Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.